Back to Search Start Over

Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality

Authors :
Han, Hui-Chen
Wang, Jia
Birnie, David H.
Alings, Marco
Philippon, François
Parkash, Ratika
Manlucu, Jaimie
Angaran, Paul
Rinne, Claus
Coutu, Benoit
Low, R. Aaron
Essebag, Vidal
Morillo, Carlos
Healey, Jeffrey S.
Redfearn, Damian
Toal, Satish
Becker, Giuliano
DeGrâce, Michel
Thibault, Bernard
Crystal, Eugene
Tung, Stanley
LeMaitre, John
Sultan, Omar
Bennett, Matthew
Bashir, Jamil
Ayala-Paredes, Felix
Gervais, Philippe
Rioux, Leon
Hemels, Martin E. W.
Bouwels, Leon H. R.
Exner, Derek V.
Dorian, Paul
Connolly, Stuart J.
Longtin, Yves
Krahn, Andrew D.
Source :
JAMA Cardiology; May 2023, Vol. 8 Issue: 5 p484-491, 8p
Publication Year :
2023

Abstract

IMPORTANCE: Cardiac implantable electronic device (CIED) infection is a potentially devastating complication with an estimated 12-month mortality of 15% to 30%. The association of the extent (localized or systemic) and timing of infection with all-cause mortality has not been established. OBJECTIVE: To evaluate the association of the extent and timing of CIED infection with all-cause mortality. DESIGN, SETTING, AND PARTICIPANTS: This prospective observational cohort study was conducted between December 1, 2012, and September 30, 2016, in 28 centers across Canada and the Netherlands. The study included 19 559 patients undergoing CIED procedures, 177 of whom developed an infection. Data were analyzed from April 5, 2021, to January 14, 2023. EXPOSURES: Prospectively identified CIED infections. MAIN OUTCOMES AND MEASURES: Time-dependent analysis of the timing (early [≤3 months] or delayed [3-12 months]) and extent (localized or systemic) of infection was performed to determine the risk of all-cause mortality associated with CIED infections. RESULTS: Of 19 559 patients undergoing CIED procedures, 177 developed a CIED infection. The mean (SD) age was 68.7 (12.7) years, and 132 patients were male (74.6%). The cumulative incidence of infection was 0.6%, 0.7%, and 0.9% within 3, 6, and 12 months, respectively. Infection rates were highest in the first 3 months (0.21% per month), reducing significantly thereafter. Compared with patients who did not develop CIED infection, those with early localized infections were not at higher risk for all-cause mortality (no deaths at 30 days [0 of 74 patients]: adjusted hazard ratio [aHR], 0.64 [95% CI, 0.20-1.98]; P = .43). However, patients with early systemic and delayed localized infections had an approximately 3-fold increase in mortality (8.9% 30-day mortality [4 of 45 patients]: aHR, 2.88 [95% CI, 1.48-5.61]; P = .002; 8.8% 30-day mortality [3 of 34 patients]: aHR, 3.57 [95% CI, 1.33-9.57]; P = .01), increasing to a 9.3-fold risk of death for those with delayed systemic infections (21.7% 30-day mortality [5 of 23 patients]: aHR, 9.30 [95% CI, 3.82-22.65]; P < .001). CONCLUSIONS AND RELEVANCE: Findings suggest that CIED infections are most common within 3 months after the procedure. Early systemic infections and delayed localized infections are associated with increased mortality, with the highest risk for patients with delayed systemic infections. Early detection and treatment of CIED infections may be important in reducing mortality associated with this complication.

Details

Language :
English
ISSN :
23806583 and 23806591
Volume :
8
Issue :
5
Database :
Supplemental Index
Journal :
JAMA Cardiology
Publication Type :
Periodical
Accession number :
ejs63007835
Full Text :
https://doi.org/10.1001/jamacardio.2023.0467